China-born biologist Zhang Feng has been awarded the United ... of his work developing the revolutionary gene-editing tool CRISPR-Cas9. According to the citation from the US Patent and Trademark ...

China-born biologist Zhang Feng has been awarded the United States ... work developing the revolutionary gene-editing tool CRISPR-Cas9. According to the citation from the US Patent and Trademark ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony China-born biologist Zhang Feng has been awarded the United States' highest honour for ...

Researchers at the Broad Institute of MIT and Harvard and Cyrus Biotechnology have now engineered two CRISPR nucleases, Cas9 and Cas12 ... The study was led by Feng Zhang, a core institute ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu from Wells Fargo maintained a Hold rating on the ...

Beam was formed in 2017 by David Liu, Feng Zhang, and Keith Joung, all pioneers of CRISPR gene editing. In October 2023, the biotech opted to cut one in five of its workforce and shelve R&D ...

It's clear though that these companies need time. Even with the only approved CAS9 based treatment out there, CRISPR is still years away from achieving its potential. In a recent update to ...

Intellia Therapeutics' most advanced product candidates, NTL-2002 and Next-z, are aimed as in vivo gene therapies, using Crispr/Cas9 encapsulated in their proprietary LNP, which after being ...